Ignite Creation Date:
2024-05-06 @ 6:01 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05512780
Status:
UNKNOWN
Last Update Posted:
2022-08-23
First Post:
2022-08-22
Brief Title:
Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positiveHER2-negative Breast Cancer
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Hebei Medical University Fourth Hospital
Organization Data
Organization:
Hebei Medical University Fourth Hospital
Class:
OTHER
Study ID:
2022037
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hebei Medical University Fourth Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None